Position in GILD
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$439,663
-$45,344 QoQ
Shares Held
3,480
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#1,442
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 20%
Shared 0%
None 80%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BOURNE LENT ASSET MANAGEMENT INC holds $19,951,025 across 7 Drug Manufacturers - General names. GILD ranks #7 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
117,066 | $6,745,342 | |
| 2 | LLY |
ELI LILLY & Co
|
3,887 | $4,662,184 | |
| 3 | AMGN |
Amgen Inc
|
9,860 | $3,570,503 | |
| 4 | JNJ |
Johnson & Johnson
|
12,206 | $3,099,957 | |
| 5 | PFE |
Pfizer Inc
|
36,275 | $873,502 | |
| 6 | MRK |
Merck & Co., Inc.
|
4,357 | $559,874 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
3,480 | $439,663 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $439,663 | 3,480 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $485,007 | 3,480 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $427,135 | 3,480 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $386,280 | 3,480 | Shares | Sole | 2025-12-15 | |
| 2025-06-30 | $385,827 | 3,480 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $389,934 | 3,480 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $330,684 | 3,580 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $300,147 | 3,580 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $245,623 | 3,580 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $262,235 | 3,580 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $290,015 | 3,580 | Shares | Other | 2024-01-19 | |
| 2023-09-30 | $642,985 | 8,580 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $661,260 | 8,580 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $711,882 | 8,580 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $736,593 | 8,580 | Shares | Other | 2023-01-24 | |
| 2022-09-30 | $523,131 | 8,480 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $517,967 | 8,380 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $498,191 | 8,380 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $593,949 | 8,180 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $571,373 | 8,180 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $563,274 | 8,180 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $494,742 | 7,655 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $434,328 | 7,455 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $471,081 | 7,455 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $573,587 | 7,455 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $557,335 | 7,455 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||